BTG plc (LON:BTG – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 840 ($10.63) and traded as high as GBX 840 ($10.63). BTG shares last traded at GBX 840 ($10.63), with a volume of 271,742 shares.
BTG Stock Performance
The stock has a 50 day simple moving average of GBX 840 and a 200 day simple moving average of GBX 840. The stock has a market cap of £3.26 billion and a P/E ratio of 29.47.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
See Also
- Five stocks we like better than BTG
- How to Use the MarketBeat Stock Split Calculator
- 5 Trends You Need to Know This Quarter
- Trading Halts Explained
- MarketBeat Week in Review – 4/8 – 4/12
- 10 Best Airline Stocks to Buy
- You Can Follow BlackRock’s Market View for Your Money
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
